United States securities and exchange commission logo





                              June 7, 2023

       Lewis Bender
       Chief Executive Officer
       Intensity Therapeutics, Inc.
       61 Wilton Road, 3rd Floor
       Westport, CT 06880

                                                        Re: Intensity
Therapeutics, Inc.
                                                            Amendment No. 13 to
Registration Statement on Form S-1
                                                            Filed May 18, 2023
                                                            File No. 333-260565

       Dear Lewis Bender:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 13 to Form S-1 filed May 18, 2023

       Facilities, page 101

   1.                                                   We note your disclosure
on page 101 that you have provided notice that the Westport
                                                        lease would terminate
on June 30, 2023. However, you also disclose on page F-43 that
                                                        the lease expires as of
September 2023. Please clarify the term of the lease and revise
                                                        accordingly. Please
also file the lease agreement as an exhibit to the registration statement
                                                        pursuant to Item
601(b)(10) of Regulation S-K.
              You may contact Sasha Parikh at 202-551-3627 or Al Pavot at
202-551-3738 if you have
       questions regarding comments on the financial statements and related
matters. Please contact
       Jane Park at 202-551-7439 or Suzanne Hayes at 202-551-3675 with any
other questions.
 Lewis Bender
Intensity Therapeutics, Inc.
June 7, 2023
Page 2

                                            Sincerely,
FirstName LastNameLewis Bender
                                            Division of Corporation Finance
Comapany NameIntensity Therapeutics, Inc.
                                            Office of Life Sciences
June 7, 2023 Page 2
cc:       Daniel Woodard, Esq.
FirstName LastName